Let's skip the reassurance-first approach and go straight to the numbers. Finasteride does cause erectile dysfunction in some men. The question — the only question that matters for your decision — is how many, how severe, and what can you do about it.
The Clinical Trial Data
Finasteride
Placebo
Difference
by Year 5
The Merck Phase III clinical trials enrolled 1,879 men and tracked sexual side effects meticulously. The results: 1.3% of men on finasteride reported ED, compared to 0.7% on placebo. The absolute difference attributable to the drug: 0.6%.
That means for every 167 men who take finasteride, roughly one will experience ED that wouldn't have occurred on placebo. The other 166 will not.
Two additional data points that matter:
Side effects resolved with discontinuation — and in most men who continued therapy. The majority of men who experienced sexual side effects saw them resolve even while staying on the drug.
By year 5, the incidence dropped to ≤0.3%. The 5-year PLESS trial showed no difference between finasteride and placebo in sexual adverse events during years 2–4. Side effects that occur tend to emerge early and diminish over time.
The Nocebo Effect: When Awareness Creates Symptoms
The Mondaini nocebo study (Journal of Sexual Medicine, 2007) is one of the most important pieces of finasteride research ever conducted — and it's almost never cited in consumer health content.
The study divided men starting finasteride into two groups. One group was informed about potential sexual side effects. The other was not informed. The results:
Informed group: 43.6% reported sexual side effects.
Uninformed group: 15.3% reported sexual side effects.
The effects in the informed group were completely reversible within 5 days of discontinuation, suggesting they were psychologically mediated rather than pharmacologically caused.
This doesn't mean all finasteride side effects are in your head. But it does mean that what you expect to happen significantly influences what you experience. Men who spend hours reading finasteride horror stories online — which is exactly the audience reading this article — are statistically more likely to experience side effects than men who simply take the drug without overthinking it.
The honest take: the nocebo effect is real and powerful, AND finasteride genuinely causes sexual side effects in a small percentage of men. Both things are true simultaneously.
If You Do Experience ED: The Solution
Here's the part that no other hair loss site covers properly, because no other hair loss site has the perspective (or the affiliate relationships) to address it: finasteride-related ED is treatable.
PDE5 inhibitors — sildenafil (Viagra), tadalafil (Cialis), and others — are highly effective treatments for erectile dysfunction regardless of the cause. And there is no drug interaction between finasteride and PDE5 inhibitors. They work through completely different mechanisms:
Finasteride blocks 5-alpha reductase (an enzyme involved in hormone conversion). It operates in the androgen pathway.
PDE5 inhibitors increase nitric oxide availability and blood flow to erectile tissue. They operate in the vascular pathway.
No shared pathways. No metabolic competition. No drug interactions. Many men take both medications concurrently without any issues.
The practical message: you don't have to choose between your hair and your sex life. If finasteride is working for your hair and you develop mild ED, the ED is treatable — often with a low-dose daily tadalafil (2.5–5 mg) that you take once in the morning and don't think about again.
What the 5-Year Data Shows
The long-term data is reassuring. The 5-year PLESS trial (Proscar Long-Term Efficacy and Safety Study) showed that sexual side effects with finasteride decreased over time rather than accumulating. By years 2–4, there was no statistically significant difference between finasteride and placebo in sexual adverse event rates.
The 10-year Japanese study (Yanagisawa, 532 men) reported adverse reactions in 6.8% of participants over the full decade — all mild and temporary, with no serious adverse reactions during the entire study period. This is the longest controlled finasteride dataset available, and it's remarkably clean.
Making Your Decision
The risk-benefit calculation comes down to this: a 0.6% absolute increase in ED risk (which is usually mild, usually temporary, and treatable if persistent) versus the documented ability to halt and reverse hair loss in the majority of men who take it.
If you're in the 99.4% who don't experience ED, you get your hair back (or keep what you have) with no sexual side effects. If you're in the 0.6% who do, the ED is treatable with widely available, well-understood medications that work through a completely separate mechanism.
Talk to a Provider
A licensed provider can help you weigh the risks and benefits for your specific situation — and prescribe ED treatment if needed.
Find a ProviderAffiliate link · Sesame Care · Consultations from $44
Finasteride causes ED in 1.3% of users vs 0.7% on placebo — an absolute difference of 0.6%. The nocebo effect is documented and significant (43.6% vs 15.3% when informed of potential side effects). Side effects typically resolve with continued use or discontinuation, and the incidence drops to ≤0.3% by year 5. For the small minority who do experience persistent ED, PDE5 inhibitors (sildenafil, tadalafil) are safe to use with finasteride — no drug interactions — and are highly effective. You don't have to choose between your hair and your sex life.